Evidence map›Paper›PMID 41526379›Full record

ArticleNature communications2026

DOT1L activity limits transcription elongation velocity and favors RNAPII pausing to facilitate mutagenesis by AID.

Poorani Ganesh Subramani, Noé Seija, Jana Ridani, Jonathan Boulais, Paul A Donnelly, Mélanie Provencher, Halil Bagci, Christian Poitras, Jean-François Côté, François Robert and 1 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Poorani Ganesh Subramani *Institut de recherches cliniques de Montréal, Montréal, QC, Canada.ORCID http://orcid.org/0000-0002-7318-6577
Noé Seija *Institut de recherches cliniques de Montréal, Montréal, QC, Canada.ORCID http://orcid.org/0000-0003-2223-1291
Jana RidaniInstitut de recherches cliniques de Montréal, Montréal, QC, Canada.
Jonathan BoulaisInstitut de recherches cliniques de Montréal, Montréal, QC, Canada.ORCID http://orcid.org/0000-0003-1848-0068
Paul A DonnellyInstitut de recherches cliniques de Montréal, Montréal, QC, Canada.ORCID http://orcid.org/0009-0003-6069-952X
Mélanie ProvencherInstitut de recherches cliniques de Montréal, Montréal, QC, Canada.
Halil BagciInstitut de recherches cliniques de Montréal, Montréal, QC, Canada.ORCID http://orcid.org/0000-0003-2448-820X
Christian PoitrasInstitut de recherches cliniques de Montréal, Montréal, QC, Canada.ORCID http://orcid.org/0000-0001-6444-7600
Jean-François CôtéInstitut de recherches cliniques de Montréal, Montréal, QC, Canada.ORCID http://orcid.org/0000-0001-7055-2642
François RobertInstitut de recherches cliniques de Montréal, Montréal, QC, Canada.ORCID http://orcid.org/0000-0003-1054-5920
Javier M Di NoiaInstitut de recherches cliniques de Montréal, Montréal, QC, Canada. javier.di.noia@ircm.qc.ca.ORCID http://orcid.org/0000-0003-2896-0321

Funding

Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) PJ-155944Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) PJ-497331
6 · The paper itself

Abstract

Activation-induced deaminase (AID) mutates immunoglobulin genes to initiate antibody diversification by class switch recombination and somatic hypermutation but can also target non-immunoglobulin loci with oncogenic consequences. The mechanisms determining gene susceptibility to AID remain unclear. Here, we show that the H3K79 histone methyltransferase DOT1L is proximal to nuclear AID and promotes both class switch recombination and off-target AID activity, including Igh-cMyc translocations in mouse B cells. AID-mutated genes display high DOT1L activity. In the absence of DOT1L, nascent transcription largely increases despite reduced RNA Polymerase II (RNAPII) occupancy. Integrative genomic analyses reveal that DOT1L locally restricts transcription elongation velocity proportionally to H3K79me2/3 levels and extends RNAPII pausing. These transcriptional conditions enhance AID occupancy and thereby its activity. Our findings provide a harmonizing explanation for the bidirectional gene expression changes observed in DOT1L-deficient cells, and link attenuated transcriptional elongation velocity and prolonged RNAPII pausing to productive AID engagement at target loci.

Indexed as

Cytidine DeaminaseHistone-Lysine N-MethyltransferaseMutagenesisRNA Polymerase IITranscription Elongation, GeneticAICDA (Activation-Induced Cytidine Deaminase)AnimalsB-LymphocytesHistonesImmunoglobulin Class SwitchingMiceAICDA (Activation-Induced Cytidine Deaminase)Cytidine DeaminaseDot1l protein, mouseHistone-Lysine N-MethyltransferaseHistonesRNA Polymerase II

Identifiers

PMID41526379
PMCPMC12905297

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.